Diane Wendelken, APRN
Women's Health · Manhattan, KSNPI 1255334843
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 31.3% of the total. Reporting peaked in 2021 at $713 and has fallen 73.8% since, to $187 in 2025.
Across 111 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$611
- Organon$273
- Exeltis, USA Inc.$188
- Agile Therapeutics, Inc.$150
- Biogen$121
- Bayer$94
- plus $515 from 16 others
What the payments were for
- Food & beverage$1,952100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $611 |
| Organon | 13 | $273 |
| Exeltis, USA Inc. | 12 | $188 |
| Agile Therapeutics, Inc. | 9 | $150 |
| Biogen | 6 | $121 |
| Bayer | 5 | $94 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| Coopersurgical, Inc. | 4 | $62 |
| Evofem Biosciences, Inc. | 4 | $61 |
| Novo Nordisk | 4 | $55 |
| Myovant Sciences Inc. | 2 | $31 |
| Therapeuticsmd, Inc. | 2 | $28 |
| Coloplast | 2 | $27 |
| Aspira Women's Health Inc | 1 | $23 |
| Millicent US Inc | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Merck | 1 | $19 |
| Medtronic | 1 | $19 |
| Molnlycke Health Care US, LLC | 1 | $18 |
| Axonics, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$1,952 in reported general payments places this provider in the 85th percentile of 43 women's health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 40 | $1,090 |
Paid to pharmacies, not to this prescriber.
Other women's health in Manhattan
- Danielle BanksManhattan$169
- Stacy CorumMerriam$4K
- Marcia SnodgrassDodge City$3K
- Julie BiermannOverland Park$3K
- Jennifer PeppardMerriam$2K
- Brandi MulryanOverland Park$2K
- Patricia ArnoldMerriam$2K
- Jessica FergasonOverland Park$1K
- Mary LuderOverland Park$1K
- Anna GarrisonOverland Park$901
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.